Reactogenicity, safety and immunogenicity of a protein-based pneumococcal vaccine in Gambian children aged 2-4 years: a phase II randomized study.

Odutola, A; Ota, MO; Ogundare, EO; Antonio, M; Owiafe, P; Worwui, A; Greenwood, B; Alderson, M; Traskine, M; Verlant, V; +2 more... Dobbelaere, K; Borys, D; (2016) Reactogenicity, safety and immunogenicity of a protein-based pneumococcal vaccine in Gambian children aged 2-4 years: a phase II randomized study. Human vaccines & immunotherapeutics. ISSN 2164-5515 DOI: https://doi.org/10.1080/21645515.2015.1111496

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1080/21645515.2015.1111496

Abstract

Share

Downloads

Filename: khvi-12-02-1111496.PMC5049746.pdf

Licence: Creative Commons: Attribution 3.0

Download
[img]

Filename: SPNG 005 Cohort 1 ms submission version.docx

Licence: Creative Commons: Attribution-Noncommercial-No Derivative Works 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar